Lindner A, Charra B, Sherrard DJ, et al.. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974; 290:697–701.

• PubMed
Lindner A, Charra B, Sherrard DJ, . Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974; 290:697–701.)| false
• Search Google Scholar
• Export Citation

Ferrer Tomas R, Jara J Guías SEN. Riñón y Enfermedad Cardiovascular 2004; 24:21–26.

• PubMed
Ferrer Tomas R, Jara J Guías SEN. Riñón y Enfermedad Cardiovascular 2004; 24:21–26.)| false
• Search Google Scholar
• Export Citation

Bover J, Ortiz F, Cabezas A, et al.. Nuevos conceptos sobre enfermedad renal crónica y sus implicaciones, Act Fund Puigvert 2004; 23:176–191.

• PubMed
Bover J, Ortiz F, Cabezas A, . Nuevos conceptos sobre enfermedad renal crónica y sus implicaciones, Act Fund Puigvert 2004; 23:176–191.)| false
• Search Google Scholar
• Export Citation

Pérez SG, Ortiz F, Ballarín J, Bover J. Enfermedad cardiovascular en pacientes con enfermedad renal crónica: modelo experimental para la evaluación del eje cardio-renal. Act Fund Puigvert 2006; 25:189–194.

• PubMed
Pérez SG, Ortiz F, Ballarín J, Bover J. Enfermedad cardiovascular en pacientes con enfermedad renal crónica: modelo experimental para la evaluación del eje cardio-renal. Act Fund Puigvert 2006; 25:189–194.)| false
• Search Google Scholar
• Export Citation

Ronco C, Haapio M, House AA, et al.. Cardiorenal syndrome, J Am Coll Cardiol 2008; 52:1527–1539.

• PubMed
Ronco C, Haapio M, House AA, . Cardiorenal syndrome, J Am Coll Cardiol 2008; 52:1527–1539.)| false
• Search Google Scholar
• Export Citation

Levey AS, Beto JA, Coronado BE, et al.. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis 1998; 32:853–906.

• PubMed
Levey AS, Beto JA, Coronado BE, . Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis 1998; 32:853–906.)| false
• Search Google Scholar
• Export Citation

Sarnak MJ, Levey AS, Schoolwerth AC, et al.. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 108:2154–2169.

• PubMed
Sarnak MJ, Levey AS, Schoolwerth AC, . Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 108:2154–2169.)| false
• Search Google Scholar
• Export Citation

Foley RN, Parfrey PS, Harnett JD, et al.. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 1996; 49:1379–1385.

• PubMed
Foley RN, Parfrey PS, Harnett JD, . Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 1996; 49:1379–1385.)| false
• Search Google Scholar
• Export Citation

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39:S1–266.

• PubMed
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39:S1–266.)| false
• Search Google Scholar
• Export Citation

Levey AS, Eckardt KU, Tsukamoto Y, et al.. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67:2089–2100.

• PubMed
Levey AS, Eckardt KU, Tsukamoto Y, . Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67:2089–2100.)| false
• Search Google Scholar
• Export Citation

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7). Hypertension 2003; 42:1206–1252.

• PubMed
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7). Hypertension 2003; 42:1206–1252.)| false
• Search Google Scholar
• Export Citation

Gracia S, Montañés R, Bover J, et al.. Recommendations for the use of equations to estimate glomerular filtration rate in adults. Spanish Society of Nephrology. Nefrologia 2006; 26:658–665.

• PubMed
Gracia S, Montañés R, Bover J, . Recommendations for the use of equations to estimate glomerular filtration rate in adults. Spanish Society of Nephrology. Nefrologia 2006; 26:658–665.)| false
• Search Google Scholar
• Export Citation

Foley RN, Parfrey PS, Sarnak MJ: Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998; 9(12 Suppl).

• PubMed
Foley RN, Parfrey PS, Sarnak MJ: Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998; 9(12 Suppl).)| false
• Search Google Scholar
• Export Citation

Bover J, Górriz JL, Martín de Francisco AL, et al.. Unawareness of the K/DOQI guidelines for bone and mineral metabolism in predialysis chronic kidney disease: results of the OSERCE Spanish multicenter-study survey. Nefrologia 2008; 28:637–643.

• PubMed
Bover J, Górriz JL, Martín de Francisco AL, . Unawareness of the K/DOQI guidelines for bone and mineral metabolism in predialysis chronic kidney disease: results of the OSERCE Spanish multicenter-study survey. Nefrologia 2008; 28:637–643.)| false
• Search Google Scholar
• Export Citation

Dikow R, Kihm LP, Zeier M, et al.. Increased infarct size in uremic rats: reduced ischemia tolerance? J Am Soc Nephrol 2004; 15:1530–1536.

• PubMed
Dikow R, Kihm LP, Zeier M, . Increased infarct size in uremic rats: reduced ischemia tolerance? J Am Soc Nephrol 2004; 15:1530–1536.)| false
• Search Google Scholar
• Export Citation

van Dokkum RP, Eijkelkamp WB, Kluppel AC, et al.. Myocardial infarction enhances progressive renal damage in an experimental model for cardio-renal interaction. J Am Soc Nephrol 2004; 15:3103–3110.

• PubMed
van Dokkum RP, Eijkelkamp WB, Kluppel AC, . Myocardial infarction enhances progressive renal damage in an experimental model for cardio-renal interaction. J Am Soc Nephrol 2004; 15:3103–3110.)| false
• Search Google Scholar
• Export Citation

Fernández-Llama P, Bover J. Is albuminuria a marker of arterial remodeling? J Hypertens 2008; 26:633–635.

• PubMed
Fernández-Llama P, Bover J. Is albuminuria a marker of arterial remodeling? J Hypertens 2008; 26:633–635.)| false
• Search Google Scholar
• Export Citation

Ochodnicky P, de Zeeuw D, Henning RH, et al.. Endothelial function predicts the development of renal damage after combined nephrectomy and myocardial infarction. J Am Soc Nephrol 2006; 17(4 Suppl 2):S49–52.

• PubMed
Ochodnicky P, de Zeeuw D, Henning RH, . Endothelial function predicts the development of renal damage after combined nephrectomy and myocardial infarction. J Am Soc Nephrol 2006; 17(4 Suppl 2):S49–52.)| false
• Search Google Scholar
• Export Citation

Fedulov AV, Ses TP, Gavrisheva NA, et al.. Serum TGF-β 1 and TNF-alpha levels and cardiac fibrosis in experimental chronic renal failure. Immunol Invest 2005; 34:143–152.

• PubMed
Fedulov AV, Ses TP, Gavrisheva NA, . Serum TGF-β 1 and TNF-alpha levels and cardiac fibrosis in experimental chronic renal failure. Immunol Invest 2005; 34:143–152.)| false
• Search Google Scholar
• Export Citation

Wong LS, Windt WA, Roks AJ, et al.. Renal failure induces telomere shortening in the rat heart. Neth Heart J 2009 May; 17(5):190–194.

• PubMed
Wong LS, Windt WA, Roks AJ, . Renal failure induces telomere shortening in the rat heart. Neth Heart J 2009 May; 17(5):190–194.)| false
• Search Google Scholar
• Export Citation

Brymora A, Flisiński M, Grześk G, et al.. Inflammation, malnutrition and vascular contraction in experimental chronic kidney disease. J Nephrol 2007; 20:423–429.

• PubMed
Brymora A, Flisiński M, Grześk G, . Inflammation, malnutrition and vascular contraction in experimental chronic kidney disease. J Nephrol 2007; 20:423–429.)| false
• Search Google Scholar
• Export Citation

Pérez S, Bernasconi A, Ballarín J, et al.. La enfermedad cardiovascular en pacientes con insuficiencia renal crónica: el eje cardiorenal. Rev Argent Cardiol 2008; 76:215–218.

• PubMed
Pérez S, Bernasconi A, Ballarín J, . La enfermedad cardiovascular en pacientes con insuficiencia renal crónica: el eje cardiorenal. Rev Argent Cardiol 2008; 76:215–218.)| false
• Search Google Scholar
• Export Citation

Pérez S, Ortiz F, Ballarín J, Bover J. Enfermedad cardiovascular en pacientes con enfermedad renal crónica: modelo experimental para la evaluación del eje cardio-renal. Act Fund Puigvert 2006; 25(4):189–194.

• PubMed
Pérez S, Ortiz F, Ballarín J, Bover J. Enfermedad cardiovascular en pacientes con enfermedad renal crónica: modelo experimental para la evaluación del eje cardio-renal. Act Fund Puigvert 2006; 25(4):189–194.)| false
• Search Google Scholar
• Export Citation

Buzello M, Torniq J, Faulhaber J, et al.. The apolipoprotein E knockout mouse: a model documenting accelerated atherogenesis in uremia. J Am Soc Nephrol 2003; 14:311–316.

• PubMed
Buzello M, Torniq J, Faulhaber J, . The apolipoprotein E knockout mouse: a model documenting accelerated atherogenesis in uremia. J Am Soc Nephrol 2003; 14:311–316.)| false
• Search Google Scholar
• Export Citation

Davies MR, Lund RJ, Mathew S, Hruska KA. Low turnover osteodystrophy and vascular calcification are amenable to skeletal anabolism in an animal model of chronic kidney disease and the metabolic syndrome. JAm Soc Nephrol 2005; 16:917–928.

• PubMed
Davies MR, Lund RJ, Mathew S, Hruska KA. Low turnover osteodystrophy and vascular calcification are amenable to skeletal anabolism in an animal model of chronic kidney disease and the metabolic syndrome. JAm Soc Nephrol 2005; 16:917–928.)| false
• Search Google Scholar
• Export Citation

Li Y, Takemura G, Okada H, et al.. Molecular signaling mediated by angiotensin II type 1A receptor blockade leading to attenuation of renal dysfunction-associated heart failure. J Card Fail 2007; 13:155–162.

• PubMed
Li Y, Takemura G, Okada H, . Molecular signaling mediated by angiotensin II type 1A receptor blockade leading to attenuation of renal dysfunction-associated heart failure. J Card Fail 2007; 13:155–162.)| false
• Search Google Scholar
• Export Citation